IRB Acquisition Edge IRB Company was acquired by Advarra, a leading IRB and research services provider, suggesting potential synergy opportunities for cross-selling expanded compliance and technology offerings to a broader client base in pharmaceutical, biotech, and devices sectors.

Private IRB Expertise As a long-standing private IRB operating since 1981 with AAHRPP accreditation, IRBCo demonstrates deep domain expertise and credibility that can be leveraged to win contracts with mid-market biotech firms and CROs seeking trusted next-step IRB partnerships.

Mid-Sized Focus The company employs 11-50 people with revenue in the low single-digit millions, indicating a target profile for scalable, cost-efficient IRB services—opportunities to position high-value, flexible review solutions to small to mid-size sponsors and research units.

Tech Stack Gap Current technology stack includes DreamWeaver and jQuery with PHP and Google Analytics, signaling room to propose modern, secure IRB workflow platforms and upgrade paths to clients requiring streamlined submissions, tracking, and reporting.

Industry Positioning Operating in pharmaceutical, biotechnology, and medical device spaces with a history of central IRB services positions IRBCo to align with sponsor consolidation trends and demand for compliant, efficient review processes across clinical research programs.